InvestorsObserver
×
News Home

ReShape Lifesciences Inc (RSLS) is down -12.59% in a Week, Should You Accumulate?

Thursday, August 10, 2023 11:07 AM | InvestorsObserver Analysts

Mentioned in this article

ReShape Lifesciences Inc (RSLS) is down -12.59% in a Week, Should You Accumulate?

A rating of 55 puts ReShape Lifesciences Inc (RSLS) near the middle of the Medical Devices industry according to InvestorsObserver. ReShape Lifesciences Inc's score of 55 means it scores higher than 55% of stocks in the industry. ReShape Lifesciences Inc also received an overall rating of 45, putting it above 45% of all stocks. Medical Devices is ranked 79 out of the 148 industries.

Overall Score - 45
RSLS has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on RSLS!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 45 would rank higher than 45 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With ReShape Lifesciences Inc Stock Today?

ReShape Lifesciences Inc (RSLS) stock is trading at $1.25 as of 11:05 AM on Thursday, Aug 10, a gain of $0.05, or 3.79% from the previous closing price of $1.20. The stock has traded between $1.25 and $1.30 so far today. Volume today is light. So far 8,866 shares have traded compared to average volume of 119,831 shares. Click Here to get the full Stock Report for ReShape Lifesciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App